Clinical Topics
-
Despite benefits, extended-interval pembro uptake remains low -
Time to cancer diagnoses in U.S. averages 5 months -
Opioids after lung cancer surgery may up all-cause mortality risk -
Gene mutations may drive lung cancer in never-smokers -
Reporting Coronary Artery Calcium on Low-Dose Computed Tomography Impacts Statin Management in a Lung Cancer Screening Population
Digital Edition
Multimedia
Conference Coverage
-
Cannabis in Cancer: What Oncologists and Patients Should Know -
MUC-1 vaccine associated with notable overall survival rates in breast cancer -
One Patient Changed This Oncologist’s View of Hope. Here’s How. -
‘Groundbreaking’ Trial Shows Survival Benefits in Lung Cancer -
LDCT Lung Cancer Screening Finds Undiagnosed Pulmonary Comorbidities in High-Risk Population -
New mRNA Vaccines in Development for Cancer and Infections -
No Routine Cancer Screening Option? New MCED Tests May Help -
-
It Takes a Village: Treating Patients for NSCLC Brain Metastases -
Subcutaneous Immunotherapy Promises Better Life For Cancer Patients
Question 1 of 5
